Why is Nvidia stock surging after Saudi AI deals?
How will Trump's Middle East visit impact US tech?
What caused American Eagle to withdraw 2025 guidance?
Why is Ford recalling Expedition and Navigator SUVs?
How will easing Syria sanctions affect the region?
What drove Saudi Aramco's $90 billion US agreements?
Why is Microsoft cutting thousands of jobs now?
How is the US-Canada trade agreement affecting business?
What are the implications of Trump's $400M Qatar plane?
Exelixis Crushes Q1 Earnings Estimates With Strong Cabometyx Sales, Raises 2025 Revenue Guidance
benzinga.com/general/biotech/25/05/45410642/exelixis-crushes-q1-earnings-estimates-with-strong-cabometyx-sales-raises-2025-revenue-guidance
Exelixis Inc. (NASDAQ:EXEL) reported adjusted earnings of 62 cents per share on Tuesday for the first quarter of 2025, compared to 17 cents a year ago, beating the consensus of 36 cents.
The cancer-focused company reported quarterly sales of $555.45 million, beating the consensus of…
This story appeared on benzinga.com, 2025-05-14 14:44:27.